Selected research
Market Analysis & Forecast
Global Endorphins Market Analysis and Forecast 2026-2032
Market perspective
The global Endorphins market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Endorphins is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Endorphins is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Endorphins is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Endorphins is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Endorphins include Assertio Therapeutics Inc., Cipher Pharmaceuticals Inc., Egalet Corp., Endo International Plc, Lannett Co. Inc., Pfizer and Johnson & Johnson, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Endorphins, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Endorphins, also provides the sales of main regions and countries. Of the upcoming market potential for Endorphins, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Endorphins sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Endorphins market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Endorphins sales, projected growth trends, production technology, application and end-user industry.
Endorphins Segment by Company
Assertio Therapeutics Inc.
Cipher Pharmaceuticals Inc.
Egalet Corp.
Endo International Plc
Lannett Co. Inc.
Pfizer
Johnson & Johnson
Endorphins Segment by Type
Sigma-Endorphins
Gamma-Endorphins
Beta-Endorphins
Alpha-Endorphins
Endorphins Segment by Application
Institutional Pharmacies
Retail Pharmacies
Online Pharmacies
Endorphins Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Endorphins market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Endorphins and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Endorphins.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Endorphins in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Endorphins manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Endorphins sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Sigma-Endorphins
- Gamma-Endorphins
- Beta-Endorphins
- Alpha-Endorphins
Applications
- Institutional Pharmacies
- Retail Pharmacies
- Online Pharmacies
Companies covered
- Assertio Therapeutics Inc.
- Cipher Pharmaceuticals Inc.
- Egalet Corp.
- Endo International Plc
- Lannett Co. Inc.
- Pfizer
- Johnson & Johnson
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Endorphins Market by Type
- 1.2.1 Global Endorphins Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Sigma-Endorphins
- 1.2.3 Gamma-Endorphins
- 1.2.4 Beta-Endorphins
- 1.2.5 Alpha-Endorphins
- 1.3 Endorphins Market by Application
- 1.3.1 Global Endorphins Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Institutional Pharmacies
- 1.3.3 Retail Pharmacies
- 1.3.4 Online Pharmacies
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Endorphins Market Dynamics
- 2.1 Endorphins Industry Trends
- 2.2 Endorphins Industry Drivers
- 2.3 Endorphins Industry Opportunities and Challenges
- 2.4 Endorphins Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Endorphins Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Endorphins Revenue by Region
- 3.2.1 Global Endorphins Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Endorphins Revenue by Region (2021-2026)
- 3.2.3 Global Endorphins Revenue by Region (2027-2032)
- 3.2.4 Global Endorphins Revenue Market Share by Region (2021-2032)
- 3.3 Global Endorphins Sales Estimates and Forecasts 2021-2032
- 3.4 Global Endorphins Sales by Region
- 3.4.1 Global Endorphins Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Endorphins Sales by Region (2021-2026)
- 3.4.3 Global Endorphins Sales by Region (2027-2032)
- 3.4.4 Global Endorphins Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Endorphins Revenue by Manufacturers
- 4.1.1 Global Endorphins Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Endorphins Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Endorphins Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Endorphins Sales by Manufacturers
- 4.2.1 Global Endorphins Sales by Manufacturers (2021-2026)
- 4.2.2 Global Endorphins Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Endorphins Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Endorphins Sales Price by Manufacturers (2021-2026)
- 4.4 Global Endorphins Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Endorphins Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Endorphins Manufacturers, Product Type & Application
- 4.7 Global Endorphins Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Endorphins Market CR5 and HHI
- 4.8.2 2025 Endorphins Tier 1, Tier 2, and Tier 3
5 Endorphins Market by Type
- 5.1 Global Endorphins Revenue by Type
- 5.1.1 Global Endorphins Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Endorphins Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Endorphins Revenue Market Share by Type (2021-2032)
- 5.2 Global Endorphins Sales by Type
- 5.2.1 Global Endorphins Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Endorphins Sales by Type (2021-2032) & (K Units)
- 5.2.3 Global Endorphins Sales Market Share by Type (2021-2032)
- 5.3 Global Endorphins Price by Type
6 Endorphins Market by Application
- 6.1 Global Endorphins Revenue by Application
- 6.1.1 Global Endorphins Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Endorphins Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Endorphins Revenue Market Share by Application (2021-2032)
- 6.2 Global Endorphins Sales by Application
- 6.2.1 Global Endorphins Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Endorphins Sales by Application (2021-2032) & (K Units)
- 6.2.3 Global Endorphins Sales Market Share by Application (2021-2032)
- 6.3 Global Endorphins Price by Application
7 Company Profiles
- 7.1 Assertio Therapeutics Inc.
- 7.1.1 Assertio Therapeutics Inc. Company Information
- 7.1.2 Assertio Therapeutics Inc. Business Overview
- 7.1.3 Assertio Therapeutics Inc. Endorphins Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Assertio Therapeutics Inc. Endorphins Product Portfolio
- 7.1.5 Assertio Therapeutics Inc. Recent Developments
- 7.2 Cipher Pharmaceuticals Inc.
- 7.2.1 Cipher Pharmaceuticals Inc. Company Information
- 7.2.2 Cipher Pharmaceuticals Inc. Business Overview
- 7.2.3 Cipher Pharmaceuticals Inc. Endorphins Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Cipher Pharmaceuticals Inc. Endorphins Product Portfolio
- 7.2.5 Cipher Pharmaceuticals Inc. Recent Developments
- 7.3 Egalet Corp.
- 7.3.1 Egalet Corp. Company Information
- 7.3.2 Egalet Corp. Business Overview
- 7.3.3 Egalet Corp. Endorphins Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Egalet Corp. Endorphins Product Portfolio
- 7.3.5 Egalet Corp. Recent Developments
- 7.4 Endo International Plc
- 7.4.1 Endo International Plc Company Information
- 7.4.2 Endo International Plc Business Overview
- 7.4.3 Endo International Plc Endorphins Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Endo International Plc Endorphins Product Portfolio
- 7.4.5 Endo International Plc Recent Developments
- 7.5 Lannett Co. Inc.
- 7.5.1 Lannett Co. Inc. Company Information
- 7.5.2 Lannett Co. Inc. Business Overview
- 7.5.3 Lannett Co. Inc. Endorphins Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Lannett Co. Inc. Endorphins Product Portfolio
- 7.5.5 Lannett Co. Inc. Recent Developments
- 7.6 Pfizer
- 7.6.1 Pfizer Company Information
- 7.6.2 Pfizer Business Overview
- 7.6.3 Pfizer Endorphins Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Pfizer Endorphins Product Portfolio
- 7.6.5 Pfizer Recent Developments
- 7.7 Johnson & Johnson
- 7.7.1 Johnson & Johnson Company Information
- 7.7.2 Johnson & Johnson Business Overview
- 7.7.3 Johnson & Johnson Endorphins Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Johnson & Johnson Endorphins Product Portfolio
- 7.7.5 Johnson & Johnson Recent Developments
8 North America
- 8.1 North America Endorphins Market Size by Type
- 8.1.1 North America Endorphins Revenue by Type (2021-2032)
- 8.1.2 North America Endorphins Sales by Type (2021-2032)
- 8.1.3 North America Endorphins Price by Type (2021-2032)
- 8.2 North America Endorphins Market Size by Application
- 8.2.1 North America Endorphins Revenue by Application (2021-2032)
- 8.2.2 North America Endorphins Sales by Application (2021-2032)
- 8.2.3 North America Endorphins Price by Application (2021-2032)
- 8.3 North America Endorphins Market Size by Country
- 8.3.1 North America Endorphins Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Endorphins Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Endorphins Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
9 Europe
- 9.1 Europe Endorphins Market Size by Type
- 9.1.1 Europe Endorphins Revenue by Type (2021-2032)
- 9.1.2 Europe Endorphins Sales by Type (2021-2032)
- 9.1.3 Europe Endorphins Price by Type (2021-2032)
- 9.2 Europe Endorphins Market Size by Application
- 9.2.1 Europe Endorphins Revenue by Application (2021-2032)
- 9.2.2 Europe Endorphins Sales by Application (2021-2032)
- 9.2.3 Europe Endorphins Price by Application (2021-2032)
- 9.3 Europe Endorphins Market Size by Country
- 9.3.1 Europe Endorphins Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Endorphins Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Endorphins Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Netherlands
10 China
- 10.1 China Endorphins Market Size by Type
- 10.1.1 China Endorphins Revenue by Type (2021-2032)
- 10.1.2 China Endorphins Sales by Type (2021-2032)
- 10.1.3 China Endorphins Price by Type (2021-2032)
- 10.2 China Endorphins Market Size by Application
- 10.2.1 China Endorphins Revenue by Application (2021-2032)
- 10.2.2 China Endorphins Sales by Application (2021-2032)
- 10.2.3 China Endorphins Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Endorphins Market Size by Type
- 11.1.1 Asia Endorphins Revenue by Type (2021-2032)
- 11.1.2 Asia Endorphins Sales by Type (2021-2032)
- 11.1.3 Asia Endorphins Price by Type (2021-2032)
- 11.2 Asia Endorphins Market Size by Application
- 11.2.1 Asia Endorphins Revenue by Application (2021-2032)
- 11.2.2 Asia Endorphins Sales by Application (2021-2032)
- 11.2.3 Asia Endorphins Price by Application (2021-2032)
- 11.3 Asia Endorphins Market Size by Country
- 11.3.1 Asia Endorphins Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Endorphins Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Endorphins Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Endorphins Market Size by Type
- 12.1.1 SAMEA Endorphins Revenue by Type (2021-2032)
- 12.1.2 SAMEA Endorphins Sales by Type (2021-2032)
- 12.1.3 SAMEA Endorphins Price by Type (2021-2032)
- 12.2 SAMEA Endorphins Market Size by Application
- 12.2.1 SAMEA Endorphins Revenue by Application (2021-2032)
- 12.2.2 SAMEA Endorphins Sales by Application (2021-2032)
- 12.2.3 SAMEA Endorphins Price by Application (2021-2032)
- 12.3 SAMEA Endorphins Market Size by Country
- 12.3.1 SAMEA Endorphins Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Endorphins Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Endorphins Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Endorphins Value Chain Analysis
- 13.1.1 Endorphins Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Endorphins Production Mode & Process
- 13.2 Endorphins Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Endorphins Distributors
- 13.2.3 Endorphins Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst